BI

BVF Inc Portfolio holdings

AUM $2.8B
This Quarter Return
+24.49%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$787M
AUM Growth
+$787M
Cap. Flow
+$13.5M
Cap. Flow %
1.71%
Top 10 Hldgs %
62.09%
Holding
40
New
7
Increased
11
Reduced
9
Closed
4

Top Buys

1
IRWD icon
Ironwood Pharmaceuticals
IRWD
$44.5M
2
KURA icon
Kura Oncology
KURA
$20.2M
3
ZEAL
Zealand Pharma A/S American Depositary Shares
ZEAL
$19.2M
4
CNCE
Concert Pharmaceuticals, Inc.
CNCE
$18.9M
5
ITCI
Intra-Cellular Therapies Inc.
ITCI
$15M

Top Sells

1
BPMC
Blueprint Medicines
BPMC
$40.7M
2
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
$22.8M
3
LOXO
Loxo Oncology, Inc
LOXO
$20.7M
4
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
$16M
5
OMED
OncoMed Pharmaceuticals, Inc.
OMED
$14.7M

Sector Composition

1 Healthcare 85.27%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ARRY
1
DELISTED
Array Biopharma Inc
ARRY
$78.8M 10.01% 6,402,525 +342,900 +6% +$4.22M
BPMC
2
DELISTED
Blueprint Medicines
BPMC
$70.2M 8.92% 1,007,354 -584,292 -37% -$40.7M
CCXI
3
DELISTED
ChemoCentryx, Inc.
CCXI
$56.3M 7.16% 7,587,416 -661,000 -8% -$4.9M
ANAB icon
4
AnaptysBio
ANAB
$569M
$48.2M 6.13% 1,379,134 -280,066 -17% -$9.79M
CNCE
5
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$46.2M 5.88% 3,135,289 +1,278,394 +69% +$18.9M
CBIO
6
Crescent Biopharma, Inc. Common Stock
CBIO
$200M
$45.2M 5.74% 3,229,856 +259,674 +9% +$3.63M
IRWD icon
7
Ironwood Pharmaceuticals
IRWD
$214M
$44.5M 5.65% +2,820,000 New +$44.5M
CTMX icon
8
CytomX Therapeutics
CTMX
$336M
$40.5M 5.15% 2,230,898 +203,900 +10% +$3.7M
XOMA icon
9
Xoma
XOMA
$392M
$29.5M 3.75% 1,502,800 – –
BLRX
10
BioLineRX
BLRX
$16.2M
$29.1M 3.7% 25,995,575 +8,495,575 +49% +$9.52M
CTIC
11
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$27.4M 3.49% 8,596,357 – –
LOXO
12
DELISTED
Loxo Oncology, Inc
LOXO
$22M 2.79% 238,386 -225,000 -49% -$20.7M
KURA icon
13
Kura Oncology
KURA
$686M
$20.2M 2.57% +1,353,846 New +$20.2M
OMED
14
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
– – -4,400,289 Closed -$14.7M
ZEAL
15
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
$19.2M 2.44% +1,000,000 New +$19.2M
CYTK icon
16
Cytokinetics
CYTK
$4.23B
$18M 2.29% 1,241,021 -749,300 -38% -$10.9M
PVLA
17
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
$17.2M 2.19% 2,986,562 -505,371 -14% -$2.91M
RGLS
18
DELISTED
Regulus Therapeutics
RGLS
$16.2M 2.06% 12,949,229 +9,670,329 +295% +$12.1M
ITCI
19
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$15M 1.91% +950,000 New +$15M
FBRX icon
20
Forte Biosciences
FBRX
$137M
$13.2M 1.68% 1,063,028 -216,050 -17% -$2.69M
CASC
21
DELISTED
Cascadian Therapeutics, Inc.
CASC
$12.8M 1.63% 3,133,224 – –
FSTX
22
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$11M 1.4% 652,676 +37,292 +6% +$628K
XENE icon
23
Xenon Pharmaceuticals
XENE
$2.98B
$10.6M 1.35% 3,588,830 +70,000 +2% +$206K
INFI
24
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$10.5M 1.33% 7,866,108 – –
ONCT
25
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$9.11M 1.16% 1,108,433 – –
1
2